SunRegen Selected for Phase I of BaseLaunch Accelerator

calendar icon August 10, 2017

SunRegen SBC003 project was accepted as a phase I project by BaseLaunch, which is a healthcare accelerator backed by Novartis, Pfizer, Johnson & Johnson, and Roche.

SunRegen Selected for Phase I of BaseLaunch Accelerator

Supported By:

SunRegen Healthcare AG is a biopharmaceutical company to develop drugs for the unmet medical needs of Neurodegenerative diseases and ophthalmic diseases.

Quick Links

Contacts Info

+41 76 461 6688

SunRegen Healthcare AG
Business Parc Reinach
Christoph Merian-Ring 11, 4153 Reinach Switzerland

info@sunregen.ch